AU3475693A - Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist - Google Patents

Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist

Info

Publication number
AU3475693A
AU3475693A AU34756/93A AU3475693A AU3475693A AU 3475693 A AU3475693 A AU 3475693A AU 34756/93 A AU34756/93 A AU 34756/93A AU 3475693 A AU3475693 A AU 3475693A AU 3475693 A AU3475693 A AU 3475693A
Authority
AU
Australia
Prior art keywords
angiotensin
antagonist
administering
abnormal tissue
treating abnormal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34756/93A
Inventor
Victor Joseph Dzau
Richard Ellsworth Pratt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU3475693A publication Critical patent/AU3475693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU34756/93A 1992-02-14 1993-01-15 Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist Abandoned AU3475693A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US83744692A 1992-02-14 1992-02-14
US837446 1992-02-14
US94259092A 1992-09-09 1992-09-09
US942590 1997-07-02

Publications (1)

Publication Number Publication Date
AU3475693A true AU3475693A (en) 1993-09-03

Family

ID=27125938

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34756/93A Abandoned AU3475693A (en) 1992-02-14 1993-01-15 Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist

Country Status (5)

Country Link
EP (1) EP0625902A1 (en)
JP (1) JPH07503729A (en)
AU (1) AU3475693A (en)
IL (1) IL104527A0 (en)
WO (1) WO1993015734A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3883205B2 (en) * 1994-03-29 2007-02-21 メルク エンド カンパニー インコーポレーテッド Treatment of Atherosclerosis with Angiotensin II Receptor Blocking Imidazole
SG92610A1 (en) * 1997-10-24 2002-11-19 Univ Singapore The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis
WO2008148812A1 (en) * 2007-06-07 2008-12-11 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4812462A (en) * 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
EP0498361A3 (en) * 1991-02-06 1992-09-02 Schering Corporation Combination of an angiotensin ii antagonist or renin inhibitor with a neutral endopeptidase inhibitor

Also Published As

Publication number Publication date
JPH07503729A (en) 1995-04-20
IL104527A0 (en) 1993-05-13
EP0625902A1 (en) 1994-11-30
WO1993015734A1 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
GB9504216D0 (en) Magnetic stimulator for neuro-muscular tissue
AU7689791A (en) Drug-free method for treatment of alopecia
AU4411297A (en) Combination therapy for treatment of psychoses
HK1009939A1 (en) Medicament for treating cardiac inflammatory diseases
AU4582797A (en) Methods for treatment of retinal diseases
AU1743195A (en) Method and apparatus for dual chamber cardiac pacing
AU4612593A (en) Fibrillation induction method for implantable devices
AUPN271295A0 (en) Method of treatment
AU5960394A (en) Platelet-specific therapeutic compound and method of treating platelet-mobilizing diseases
AU1463792A (en) N-substituted (alpha-imidazolyl-toluyl) pyrrole angiotensin ii antagonists for treatment of circulatory disorders
GB2298370B (en) Magnetic stimulator for neuro-muscular tissue
EP0735054A3 (en) Method of after treatment of modified polyolefins
AU3794997A (en) Treatment for itch of chicken pox
AU3730093A (en) Methods of treating diabetes
AU2685892A (en) Method of treating blood
AU3475693A (en) Method of treating abnormal tissue proliferation by administering an angiotensin ii antagonist
AU4220193A (en) Deazaaminopterins for treatment of inflammation
AU3263795A (en) Medicament for treatment or prophylaxis of incontinence
AU4585993A (en) Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
AU6294094A (en) An apparatus for medical treatment
ZA931010B (en) Method of treating abnormal tissue proliferation by administering an angiotensin II antagonist
AU5713196A (en) Method for treatment of pain
AU7113996A (en) Methods of treating beta-amyloid-associated conditions
AU6481496A (en) Apparatus and method for healing wounds using electrical stimulation
IL126158A0 (en) Method for treating substance abuse